Recent accounting scandals have left a sour taste in investors' mouths, limiting their willingness to deal with anything that even hints at potential shenanigans. Today, Accretive Health (NYSE: AH) shares were slammed after announcing a delay in reporting its quarterly financial results and withdrawing its prior guidance. Was the announcement worthy such a harsh reaction, or is there a good reason behind the delay? Follow along in the video below as Brenton Flynn runs through the news.